معرفی
Tim Triche, Jr., Ph.D., is an Associate Professor at the Van Andel Institute in the Department of Epigenetics. He earned his A.B. in chemistry from Cornell University, followed by an M.S. in biostatistics and a Ph.D. in statistical genetics from the University of Southern California. Before joining Van Andel in 2017, he was a postdoctoral fellow at USC's Norris Comprehensive Cancer Center focusing on cellular senescence in blood disorders.
As a key member of The Cancer Genome Atlas Research Network since 2011 with over a dozen high-impact publications in Nature, Cell, and NEJM, Dr. Triche specializes in epigenetics, biostatistics, and computational biology. His lab develops innovative approaches for pediatric AML research, integrating next-generation sequencing with clinical trial design to improve patient outcomes.
His work emphasizes statistical learning for patient stratification, molecular profiling of hematological cancers, and interpretable machine learning in biomedical contexts. He leads the Bioinformatics and Biostatistics Core as faculty advisor and maintains active collaborations across institutions.
- 2025 Nature Cancer study on developmental heterogeneity in cancer susceptibility
- 2024 NAR methods paper on BISCUIT multi-omics tools
- 2023 PLOS One validation of MAX regulation in pituitary adenomas
- 2022 Nature Metabolism obesity subtyping analysis
Scientific contributions include:
- Chan Zuckerberg Initiative grant (2022) for biomedical computing
- NCI SPORE grant (2021) as co-recipient
- Key role in Pediatric AML molecular mapping (2017)
